Clinical News

Mirikizumab Superior to Placebo in Treating Plaque Psoriasis

38 minutes ago

By Kenny Walter

At week 16, the static Physician’s Global Assessment scores were significantly greater in the mirikizumab group than in the placebo group.

Investigators Identify Comprehensive Research Priorities for Pediatric Dermatology

4 hours ago

By Giuliana Grossi

Pediatric care requires understanding, not only of the disease impact, but also its presentation and management in children.

Eyes with nAMD Treated with Ranibizumab Maintained Visual Acuity at SRF Resolution

16 hours ago

By Connor Iapoce

A post-hoc analysis of the HARBOR trial suggest a greater proportion of ranibizumab-treated eyes with nAMD gained/maintained visual acuity at SRF resolution.

Dietary Eliminations May Not Significantly Benefit Pediatric Eczema

17 hours ago

By Kevin Kunzmann

Though avoidance of common food allergens is a popular practice among patients with atopic dermatitis, clinical trial evidence doesn't support its benefit compared to its risks.

Antibiotics to Treat Upper Respiratory Infections Increase Risk of C Difficile Infections

18 hours ago

By Kenny Walter

The results show female patients were more likely to be diagnosed with any adverse event.

Crisis Point: Insulin Access in the United States

A special episode focuses on the issue of insulin accessibility and affordability in the United States, with four experts in the diabetes arena weighing in on the topic.

Conference Coverage

View All >>

Heather Woolery-Lloyd, MD, FAAD: Interview on Common Skin of Color Dermatoses

November 23, 2022

By Tim Smith

An interview on the SDPA 2022 presentation of Dr. Woolery-Lloyd in which she discusses dermatoses affecting patients of color.

Orit Markowitz, MD: Artificial Intelligence, Patient Knowledge on Skin Cancer

November 23, 2022

By Tim Smith

A discussion with Dr. Markowitz on her presentation from SDPA 2022, during which she described various gaps in knowledge on skin health and future innovations she hoped to see.

Ruxolitinib Cream Improves Atopic Dermatitis Pain, Anxiety and Depression Over 52 Weeks

November 23, 2022

By Kevin Kunzmann

New long-term phase 3 data show adults and adolescents both improved measures of quality of life when treated with either of 2 doses of ruxolitinib cream.

Orit Markowitz, MD: How to Distinguish Skin Cancer from Less Dangerous Skin Conditions

November 22, 2022

By Tim Smith

An interview with Dr. Markowitz on her presentation at SDPA 2022 presentation entitled ‘Skin of Color,’ regarding differentiating skin cancer from other conditions.

Video Series

View All >>

Limitations of Injectable Insulin in Type 1 and Type 2 Diabetes

Types of Insulin Formulations for Type 1 and Type 2 Diabetes

Pegcetacoplan for Treatment of Geographic Atrophy

Pathophysiology, Treatment Targets and Options in Geographic Atrophy

Multidisciplinary/Team Based Approach for Lipid Management

Emerging Therapies for Hypercholesterolemia

Dual Orexin Receptor Antagonist (DORA) for Treatment of Insomnia

Sleep and Wakefulness Pathways

Role of EDS-FLU in Clinical Practice in Nasal Polyposis

Use of Steroids After Surgery in Nasal Polyposis